Gilbert G. Fareau, MD

Associate Professor

Locations

Hub for Collaborative Medicine, 6th Floor
Froedtert Hospital
Endocrinology - Froedtert Hospital
Cancer Center - Froedtert Hospital

Contact Information

(414) 955-6844

Biography

Dr. Fareau is a board certified endocrinologist and associate professor in medicine (endocrinology and molecular medicine) at the Medical College of Wisconsin. He graduated with Honors from Trinity College, University of Dublin, and completed his residency through Dartmouth Medical School. He completed a Clinical and Research Fellowship in Endocrinology at the Baylor College of Medicine and the University of Texas, MD Anderson Cancer Center joint program, where his research interests included diagnostic and treatment strategies of endocrine cancers.

Dr. Fareau is a member of multiple societies and associations. He has been invited to present several lectures and authored peer-reviewed publications and book chapters. His patient care emphasizes treatment of endocrine related cancers, in addition to various disorders of the thyroid, adrenal, pituitary, and parathyroid glands.

Research Experience

Adenocarcinoma, Follicular
Carcinoma, Medullary
Carcinoma, Papillary
Thyroid Gland
Thyroid Neoplasms

Clinical Expertise

Adenocarcinoma, Follicular
Adenocarcinoma, Papillary
Adrenal Cortex Neoplasms
Adrenocortical Carcinoma
Carcinoma, Medullary
Carcinoma, Papillary
Endocrine Gland Neoplasms
Goiter
Graves Disease
Hashimoto Disease
Hyperthyroidism
Hypothyroidism

Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.

(Carr AA, Yen TWF, Ortiz DI, Hunt BC, Fareau G, Massey BL, Campbell BH, Doffek KL, Evans DB, Wang TS.) Thyroid. 2018 Nov;28(11):1462-1467 PMID: 30215297 SCOPUS ID: 2-s2.0-85056337359 09/15/2018
Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism.

(Lai V, Yen TW, Doffek K, Carr AA, Carroll TB, Fareau GG, Evans DB, Wang TS.) Ann Surg Oncol. 2016 Jul;23(7):2310-4 PMID: 27006125 SCOPUS ID: 2-s2.0-84961848458 03/24/2016
Management of patients with metastatic medullary thyroid carcinoma: The role for systemic therapy

(Fareau GG.) Medullary Thyroid Cancer. 20 July 2016:157-164 SCOPUS ID: 2-s2.0-85026549313 07/20/2016
The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer.

(Lai V, Yen TW, Rose BT, Fareau GG, Misustin SM, Evans DB, Wang TS.) Ann Surg Oncol. 2015 Dec;22(13):4181-6 PMID: 25851341 SCOPUS ID: 2-s2.0-84947128282 04/09/2015
Institutional experience with lateral neck dissections for thyroid cancer.

(Glenn JA, Yen TW, Fareau GG, Carr AA, Evans DB, Wang TS.) Surgery. 2015 Oct;158(4):972-8; discussion 978-80 PMID: 26187683 SCOPUS ID: 2-s2.0-84940775476 07/19/2015
A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation.

(Carr AA, Yen TW, Fareau GG, Cayo AK, Misustin SM, Evans DB, Wang TS.) J Am Coll Surg. 2014 Oct;219(4):757-64 PMID: 25053220 SCOPUS ID: 2-s2.0-84908146592 07/24/2014
Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.

(Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW.) Ann Surg Oncol. 2012 Dec;19(13):4217-22 PMID: 23010732 SCOPUS ID: 2-s2.0-84876502486 09/27/2012
Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies.

(Fareau GG, Lopez A, Stava C, Vassilopoulou-Sellin R.) Anticancer Drugs. 2008 Jul;19(6):637-44 PMID: 18525324 SCOPUS ID: 2-s2.0-53749087386 06/06/2008
Diagnostic challenges in adrenocortical carcinoma: recommendations for surveillance after surgical resection of selected adrenal nodules.

(Fareau GG, Vassilopoulou-Sellin R.) Endocr Pract. 2007 Oct;13(6):636-41 PMID: 17954420 SCOPUS ID: 2-s2.0-38449118662 10/24/2007
Hypercortisolemia and infection.

(Fareau GG, Vassilopoulou-Sellin R.) Infect Dis Clin North Am. 2007 Sep;21(3):639-57, viii PMID: 17826616 SCOPUS ID: 2-s2.0-34548437448 09/11/2007
Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.

(Fareau GG, Maldonado M, Oral E, Balasubramanyam A.) Metabolism. 2007 May;56(5):670-5 PMID: 17445543 SCOPUS ID: 2-s2.0-34147132673 04/21/2007
Skin rash after radioactive iodine caught on a cell phone camera.

(Núñez R, Sellin RV, Fareau GG, Drucker CR.) Thyroid. 2007 Mar;17(3):277-8 PMID: 17381363 SCOPUS ID: 2-s2.0-34147092108 03/27/2007